InsidersTradesSigma
Track the 南微医学 share price and the full insider trade history of the company, a publicly traded company based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 南微医学 has logged 16 insider filings. Market capitalisation: €13.7bn. The latest transaction was disclosed on 1 December 2023 (Sale). Among the most active insiders: 芮晨为. Every trade is openly available.
16
Insider Decl.
n/a
Thresholds
€1m
10 ops.
Buy Volume
€10m
6 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,844 of 28,752 companies
64.6
score / 100
Value49
Quality80
FCF yld3.2%
Earn yld4.2%
EV/EBITDA17.0x
ROE13%
Gross mgn64%
Net mgn18%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 December 2023
Declarations16 total
16 of 16 declarations
About 南微医学
南微医学 is a company in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on developing innovative medical solutions.